MARKET

HJLIW

HJLIW

HANCOCK JAFFE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2101
0.0000
0.00%
Closed 16:00 06/22 EDT
OPEN
--
PREV CLOSE
0.2101
HIGH
--
LOW
--
VOLUME
200
TURNOVER
--
52 WEEK HIGH
0.8000
52 WEEK LOW
0.0397
MARKET CAP
--
P/E (TTM)
-0.0344
1D
5D
1M
3M
1Y
5Y
Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final aggregated data for the VenoValve first-in-human trial
Benzinga · 12/15/2020 21:16
Hancock Jaffe Announces One Year Follow-up Data on Ninth VenoValve Patient
Patient Continues to Show Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / October 21, 2020 / Hancock Jaffe Laboratories, Inc.
ACCESSWIRE · 10/21/2020 16:15
BRIEF-Hancock Jaffe Laboratories Files For Offering Of Up To $4 Million Units
* HANCOCK JAFFE LABORATORIES INC FILES FOR OFFERING OF UP TO $4 MILLION UNITS - SEC FILING
Reuters · 07/02/2020 21:45
BRIEF-Hancock Jaffe Laboratories Files Prospectus Relates To Primary Issuance By Co Of Up To 1.8 Mln Shares Of Common Stock - SEC Filing
* HANCOCK JAFFE LABORATORIES INC FILES PROSPECTUS RELATES TO PRIMARY ISSUANCE BY CO OF UP TO 1.8 MILLION SHARES OF COMMON STOCK - SEC FILING
Reuters · 06/15/2020 21:32
BRIEF-Hancock Jaffe Laboratories Got Notice From Nasdaq That Panel Determined To Grant Co's Request For Continued Listing
* HANCOCK JAFFE LABORATORIES INC - GOT NOTICE FROM NASDAQ THAT PANEL DETERMINED TO GRANT CO'S REQUEST FOR CONTINUED LISTING Source text: https://bit.ly/2AuyeIr Further company coverage:
Reuters · 06/15/2020 21:26
BRIEF-Hancock Jaffe Laboratories Announces Intention To Merge With Catheter Precision
* HANCOCK JAFFE LABORATORIES INC. - HANCOCK JAFFE ANNOUNCES INTENTION TO MERGE WITH CATHETER PRECISION
Reuters · 06/01/2020 12:46
Hancock Jaffe Announces Intention to Merge with Catheter Precision
IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has signed a non-binding letter of intent to merge with Catheter Pre...
ACCESSWIRE · 06/01/2020 12:30
Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
IRVINE, CA / ACCESSWIRE / May 12, 2020 / Hancock Jaffe Laboratories, Inc. (HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received approval from the Superintendent of Health of the Natio...
ACCESSWIRE · 05/12/2020 12:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HJLIW. Analyze the recent business situations of HANCOCK JAFFE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
More
About HJLIW
Hancock Jaffe Laboratories, Inc. is a development stage medical device company. The Company is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The Company is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

Webull offers kinds of Hancock Jaffe Laboratories Inc stock information, including NASDAQ:HJLIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HJLIW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HJLIW stock methods without spending real money on the virtual paper trading platform.